Profile data is unavailable for this security.
About the company
Micro-Tech Nanjing Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sales of minimally invasive medical devices. The Company's main products include three series of endoscopic diagnosis and treatment instruments used with endoscopes, microwave ablation equipment and consumables, and disposable endoscopes. Endoscopic diagnosis and treatment equipment mainly includes biopsy, hemostasis and closure, Endoscopic Mucosal Resection (EMR)/Endoscopic Submucosal Dissection (ESD), dilation, and Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasonography (EUS) and Endobronchial Ultrasound (EBUS) products. Microwave ablation mainly includes microwave ablation instrument and microwave ablation needle series products. Disposable endoscope mainly includes disposable biliopancreatic imaging system (choledochoscope) and related consumables and other products.
- Revenue in CNY (TTM)2.48bn
- Net income in CNY527.90m
- Incorporated2000
- Employees2.40k
- LocationMicro-Tech Nanjing Co LtdNo. 10, Gaoke 3rd RoadNanjing High-tech Development ZoneNANJING 210032ChinaCHN
- Phone+86 2 558648819
- Fax+86 2 558744269
- Websitehttp://www.micro-tech.com.cn/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shinva Medical Instrument Co Ltd | 10.10bn | 668.52m | 10.23bn | 8.21k | 11.74 | 1.04 | -- | 1.01 | 1.44 | 1.44 | 21.62 | 16.18 | 0.6785 | 2.22 | 5.36 | 1,230,542.00 | 4.63 | 4.63 | 9.18 | 10.76 | 26.22 | 24.22 | 6.83 | 6.12 | 0.7893 | -- | 0.176 | 15.91 | 7.87 | -0.5342 | 30.78 | 95.70 | -5.90 | 53.59 |
| Qingdao Haier Biomedical Co Ltd | 2.28bn | 406.15m | 10.35bn | 2.64k | 25.44 | 2.37 | -- | 4.54 | 1.28 | 1.28 | 7.19 | 13.72 | 0.4069 | 4.93 | 8.41 | 865,378.00 | 7.39 | 11.49 | 9.42 | 15.22 | 49.30 | 49.98 | 18.17 | 25.20 | 2.53 | -- | 0.0295 | 26.53 | -20.36 | 22.07 | -32.41 | 28.94 | 20.64 | -- |
| Shanghai Microport EP MedTech Co Ltd | 366.21m | 19.18m | 10.43bn | 577.00 | 543.54 | 6.17 | -- | 28.48 | 0.0408 | 0.0408 | 0.7782 | 3.59 | 0.2013 | 1.18 | 9.01 | 634,687.40 | 1.05 | -- | 1.11 | -- | 61.35 | -- | 5.24 | -- | 12.39 | -- | 0.014 | -- | 26.46 | -- | 85.17 | -- | -- | -- |
| Sansure Biotech Inc | 1.20bn | 384.73m | 11.09bn | 2.01k | 29.48 | 1.49 | -- | 9.22 | 0.6448 | 0.6448 | 2.06 | 12.77 | 0.1377 | 0.8274 | 1.41 | 599,646.90 | 4.14 | 26.74 | 4.69 | 30.97 | 74.82 | 67.47 | 30.06 | 42.01 | 7.94 | -- | 0.0589 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
| Micro-Tech Nanjing Co Ltd | 2.48bn | 527.90m | 11.68bn | 2.40k | 22.11 | 3.13 | -- | 4.71 | 2.81 | 2.81 | 13.23 | 19.86 | 0.5948 | 1.62 | 6.91 | 1,032,216.00 | 12.91 | 10.74 | 14.98 | 12.82 | 64.81 | 63.04 | 21.71 | 19.37 | 5.19 | -- | 0.01 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.26bn | 551.89m | 11.74bn | 908.00 | 19.41 | 2.90 | -- | 9.32 | 4.91 | 4.91 | 11.27 | 32.80 | 0.3769 | 1.60 | 7.96 | 1,387,329.00 | 16.35 | 17.68 | 18.12 | 19.43 | 75.61 | 76.60 | 43.39 | 42.25 | 9.49 | -- | 0.008 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
| Shenzhen YHLO Biotech Co Ltd | 1.82bn | 339.81m | 12.80bn | 1.76k | 37.76 | 4.87 | -- | 7.02 | 0.5956 | 0.5956 | 3.21 | 4.62 | 0.4798 | 1.11 | 4.91 | 1,037,196.00 | 7.03 | 16.43 | 9.12 | 24.16 | 62.14 | 53.26 | 14.66 | 20.01 | 1.50 | -- | 0.1872 | 30.28 | -48.42 | 23.02 | -64.93 | 56.32 | 28.88 | -- |
| Beijing Balance Medical Technolgy Co Ltd | 382.01m | 111.83m | 13.65bn | 473.00 | 123.05 | 11.31 | -- | 35.74 | 0.8125 | 0.8125 | 2.78 | 8.84 | 0.3061 | 1.06 | 5.72 | 807,636.20 | 8.16 | 8.06 | 8.48 | 8.40 | 89.40 | 89.41 | 26.67 | 30.02 | 9.77 | -- | 0.0094 | 69.19 | 25.57 | 27.35 | 21.09 | 28.10 | 125.94 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Schroder Investment Management (Hong Kong) Ltd.as of 15 Jul 2024 | 6.74m | 3.66% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 6.02m | 3.27% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 08 Feb 2024 | 5.28m | 2.87% |
| E Fund Management Co., Ltd.as of 08 Feb 2024 | 4.82m | 2.61% |
| Hongde Fund Management Co., Ltd.as of 31 Dec 2023 | 4.69m | 2.55% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 3.39m | 1.84% |
| Hwabao WP Fund Management Co., Ltd.as of 08 Feb 2024 | 2.70m | 1.46% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 1.32m | 0.72% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 1.10m | 0.60% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 910.23k | 0.49% |
